REGN5381 in Adult Participants With Uncontrolled Hypertension

Clinical trial NCT06833190 · TERMINATED

Trial details

NCT number: NCT06833190
Sponsor: Regeneron Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Uncontrolled Hypertension

Start date: 2025-04-16
Primary completion: 2025-10-15
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.